{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:16:53Z","timestamp":1791303413006,"version":"4.1.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamadermatol.2019.4483","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T12:02:08Z","timestamp":1579694528000},"page":"288","source":"Crossref","is-referenced-by-count":47,"title":["Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China"],"prefix":"10.1001","volume":"156","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9988","key":"doi190073r1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo.","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"doi190073r2","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo.","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"doi190073r3","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-? for autoreactive CD8+ T-cell accumulation in the skin.","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"223","key":"doi190073r4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"doi190073r5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/pcmr.2017.30.issue-2","article-title":"Differential expression of CXCL9, CXCL10, and IFN-? in vitiligo and alopecia areata patients.","volume":"30","author":"Maouia","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"doi190073r6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaci.2017.07.011","article-title":"Vitiligo: mechanistic insights lead to novel treatments.","volume":"140","author":"Frisoli","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"doi190073r7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of disease activity in vitiligo: a systematic review.","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"doi190073r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo.","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi190073r9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bjd.2015.172.issue-2","article-title":"Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.","volume":"172","author":"Komen","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi190073r10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"doi190073r11","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1056\/NEJMc090205","article-title":"Vitiligo.","volume":"360","author":"Naldi","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"doi190073r12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jaad.2017.05.027","article-title":"The majority of patients presenting with vitiligo have a clinical sign of activity.","volume":"77","author":"Aboul-Fettouh","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi190073r13","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/bjd.2016.174.issue-6","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi190073r14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.det.2016.11.004","article-title":"Presentations, signs of activity, and differential diagnosis of vitiligo.","volume":"35","author":"Goh","year":"2017","journal-title":"Dermatol Clin"},{"issue":"4","key":"doi190073r15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0190-9622(00)90170-1","article-title":"Clinical and histopathologic characteristics of trichrome vitiligo.","volume":"42","author":"Hann","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi190073r16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2006.09.004","article-title":"Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.","volume":"56","author":"Nicolaidou","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi190073r17","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study.","volume":"135","author":"Cavali\u00e9","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"450","key":"doi190073r18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"doi190073r19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8+ T cells in vitiligo.","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2759139\/jamadermatology_zhang_2020_oi_190073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:08:24Z","timestamp":1583924904000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2759139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.4483","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737248881.793572141","asserted-by":"object"}]},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}